Sector Update: Healthcare Stocks Rise Late Afternoon

MT Newswires Live11-14

Healthcare stocks were higher late Friday afternoon, with the NYSE Healthcare Index rising 0.8% and the State Street Health Care Select Sector SPDR ETF (XLV) adding 0.6%.

The iShares Biotechnology ETF (IBB) was easing 0.2%.

In corporate news, AstraZeneca (AZN) has eliminated around 600 positions in its respiratory and immunology commercial teams in the US as part of its three-year program to cut costs and reallocate resources to developing new drugs, Bloomberg reported. AstraZeneca shares were up 0.3%.

Windward Bio (WWB) shares surged 72% in their Nasdaq debut on Friday after the clinical-stage biotechnology company sold 10.3 million shares at $17 apiece in its initial public offering.

NeuroPace (NPCE) shares fell 44% after it reduced its full-year revenue outlook as Q3 sales lagged market expectations, according to results posted late Thursday.

SBC Medical Group (SBC) shares jumped 31% after it said it has made a minority equity investment in Taiwan-based NeuroBrain Dynamics and agreed to jointly develop six medical AI tools for its clinic network.

Tandem Diabetes Care (TNDM) shares rose nearly 15% after the company said it obtained clearance from the US Food and Drug Administration for its automated insulin delivery system, Tandem Mobi, to be used with a tubeless cartridge and infusion set.

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Comments

We need your insight to fill this gap
Leave a comment